Clinical Trials Directory

Trials / Completed

CompletedNCT01038440

Time and Dose Evaluation of Stearidonic Acid (SDA) to Eicosapentaenoic Acid (EPA) in Red Blood Cells

Evaluation of the Relationships of Time and Dose of Eicosapentaenoic Acid and Stearidonic Acid to the Changes in Eicosapentaenoic Acid Levels in Red Blood Cells

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
137 (actual)
Sponsor
Solae, LLC · Industry
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the relationships between dose and time of consumption of stearidonic acid (SDA) and eicosapentaenoic acid (EPA) on EPA enrichment of red blood cell (RBC) membranes in men and women.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSafflower OilOne softgel consumed daily with food
DIETARY_SUPPLEMENTEPAThree different doses of EPA (0.5, 1.5 and 3.0 g/d) consumed with food daily.Subjects consuming more than 1 softgel/day (as in the groups with 1.5 and 3.0 g/d) are instructed to consume the softgels in 2 or 3 separate servings.
DIETARY_SUPPLEMENTSDAFour different doses of SDA (0.5, 1.5, 3.0 and 6.0 g/d) consumed with food daily.Subjects consuming more than 1 softgel/day (as in the groups with 1.5 and 3.0 g/d) are instructed to consume the softgels in 2 or 3 separate servings.

Timeline

Start date
2009-08-01
Primary completion
2010-03-01
Completion
2010-08-01
First posted
2009-12-24
Last updated
2012-06-18

Source: ClinicalTrials.gov record NCT01038440. Inclusion in this directory is not an endorsement.